tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Ovarian, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AntiCan↑, Pyro↑, tumCV?, CellMemb↓, cl‑Casp3↑, GSDME-N↑, ROS?, p‑P53↑, eff↓, MMP↓, Bcl-2↓, BAX↑, mtDam↑, Cyt‑c↑, TumCG↓, CD4+↑, CD8+↑,
*Inflam↓, *AntiCan↑, *AntiP↑, LC3II↑, PI3K↓, Akt↓, mTOR↓, Casp3↑, Bcl-2↓, TumAuto↑, Apoptosis↑, tumCV?,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
Lung, |
H322 |
|
|
|
Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, ROS↑, mitResp↓, ATP↓, tumCV?,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS?, 1, ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, mitResp↓, 1, MMP↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
PDK1 / PDPK1↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 2, Casp3↑, 1, cl‑Casp3↑, 1, Cyt‑c↑, 1, GSDME-N↑, 1, Pyro↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV?, 3,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
p‑P53↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↓, 1, PI3K↓, 1, TumCG↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1,
Barriers & Transport(tgid=15) ⓘ
CellMemb↓, 1, GLUT1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD4+↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1,
Infection & Microbiome(tgid=24) ⓘ
CD8+↑, 1,
Total Targets: 30
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:897 State#:% Dir#:0
wNotes=0 sortOrder:rid,rpid
Home Page